Hexagon Capital Partners LLC grew its stake in shares of Amcor plc (NYSE:AMCR – Get Rating) by 1,680.9% in the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 2,422 shares of the company's stock after acquiring an additional 2,286 shares during the period. Hexagon Capital Partners LLC's holdings in Amcor were worth $30,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also recently modified their holdings of AMCR. Center For Asset Management LLC purchased a new position in Amcor during the second quarter valued at approximately $215,000. Commonwealth Equity Services LLC increased its holdings in Amcor by 30.4% during the second quarter. Commonwealth Equity Services LLC now owns 823,897 shares of the company's stock valued at $10,241,000 after buying an additional 192,060 shares during the period. Icon Wealth Partners LLC increased its holdings in Amcor by 42.3% during the second quarter. Icon Wealth Partners LLC now owns 14,624 shares of the company's stock valued at $182,000 after buying an additional 4,349 shares during the period. Toews Corp ADV increased its holdings in Amcor by 208.0% during the second quarter. Toews Corp ADV now owns 108,100 shares of the company's stock valued at $1,344,000 after buying an additional 73,000 shares during the period. Finally, Hennion & Walsh Asset Management Inc. increased its holdings in Amcor by 19.8% during the second quarter. Hennion & Walsh Asset Management Inc. now owns 78,041 shares of the company's stock valued at $970,000 after buying an additional 12,874 shares during the period. Institutional investors own 47.76% of the company's stock.
Get
Amcor alerts:
Analyst Ratings Changes
Several brokerages recently issued reports on AMCR. Macquarie lowered shares of Amcor from an "outperform" rating to a "neutral" rating in a report on Thursday, August 18th. Jefferies Financial Group lowered shares of Amcor from a "hold" rating to an "underperform" rating in a report on Thursday, August 18th. Morgan Stanley lowered shares of Amcor from an "overweight" rating to an "equal weight" rating in a report on Thursday, August 4th. Finally, CLSA started coverage on shares of Amcor in a report on Tuesday, July 19th. They issued a "buy" rating on the stock. Two analysts have rated the stock with a sell rating, three have assigned a hold rating and one has given a buy rating to the company's stock. According to data from MarketBeat, Amcor presently has an average rating of "Hold" and a consensus price target of $12.15.
Insider Activity
In other news, insider Louis Fred Stephan sold 27,500 shares of the business's stock in a transaction on Monday, September 12th. The shares were sold at an average price of $12.46, for a total transaction of $342,650.00. Following the sale, the insider now directly owns 112,464 shares of the company's stock, valued at $1,401,301.44. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through
this link. In related news, insider Michael J. Zacka sold 1,429,959 shares of the business's stock in a transaction on Friday, September 9th. The shares were sold at an average price of $12.15, for a total transaction of $17,374,001.85. Following the completion of the transaction, the insider now directly owns 209,115 shares in the company, valued at $2,540,747.25. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at
the SEC website. Also, insider Louis Fred Stephan sold 27,500 shares of the business's stock in a transaction on Monday, September 12th. The shares were sold at an average price of $12.46, for a total transaction of $342,650.00. Following the transaction, the insider now owns 112,464 shares of the company's stock, valued at $1,401,301.44. The disclosure for this sale can be found
here. Insiders have sold 2,905,114 shares of company stock valued at $35,840,080 over the last ninety days. 0.61% of the stock is currently owned by insiders.
Amcor Price Performance
NYSE AMCR opened at $11.03 on Tuesday. The firm has a market capitalization of $16.42 billion, a P/E ratio of 20.81, a P/E/G ratio of 2.13 and a beta of 0.79. The company has a current ratio of 1.15, a quick ratio of 0.67 and a debt-to-equity ratio of 1.53. Amcor plc has a 12-month low of $10.56 and a 12-month high of $13.60. The firm's fifty day simple moving average is $12.15 and its two-hundred day simple moving average is $12.24.
Amcor (NYSE:AMCR – Get Rating) last announced its quarterly earnings data on Wednesday, August 17th. The company reported $0.24 earnings per share for the quarter, meeting analysts' consensus estimates of $0.24. The firm had revenue of $3.91 billion for the quarter, compared to analyst estimates of $3.82 billion. Amcor had a net margin of 5.53% and a return on equity of 27.37%. During the same period in the previous year, the company earned $0.23 earnings per share. Analysts forecast that Amcor plc will post 0.81 EPS for the current fiscal year.
Amcor Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Wednesday, September 28th. Stockholders of record on Thursday, September 8th were issued a dividend of $0.12 per share. This represents a $0.48 dividend on an annualized basis and a dividend yield of 4.35%. The ex-dividend date of this dividend was Wednesday, September 7th. Amcor's dividend payout ratio (DPR) is presently 90.57%.
Amcor Profile
(Get Rating)
Amcor plc develops, produces, and sells packaging products in Europe, North America, Latin America, Africa, and the Asia Pacific regions. The company operates through two segments, Flexibles and Rigid Packaging. The Flexibles segment provides flexible and film packaging products in the food and beverage, medical and pharmaceutical, fresh produce, snack food, personal care, and other industries.
Further Reading
- Get a free copy of the StockNews.com research report on Amcor (AMCR)
- Small-Cap Catalyst Pharma Is Among Market's Best Price Performers
- 3 Stocks Growing Their Businesses for 2023
- China-Based EV Maker BYD Set For Big European, Japanese Expansion
- Is Illumina Still the Gamechanger in Genomics Sequencing?
- Here's What Makes Amazon a Sum-of-All-Parts Commerce Juggernaut
Receive News & Ratings for Amcor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amcor and related companies with MarketBeat.com's FREE daily email newsletter.
